Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Cancers|September 9, 2020
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug ResistanceYunali V Ashar, Jingchun Zhou, Pranav Gupta, et al.Frontiers in Oncology|August 15, 2020
NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug ResistanceMeng Zhang, Xuan-Yu Chen, Xing-Duo Dong, et al.Cancer Communications (London, England)|June 12, 2020
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitorYuqi Yang, Ning Ji, Chao-Yun Cai, et al.Frontiers in Pharmacology|March 14, 2022
Overexpression of ABCB1 Associated With the Resistance to the KRAS-G12C Specific Inhibitor ARS-1620 in Cancer CellsXing-Duo Dong, Meng Zhang, Chao-Yun Cai, et al.Frontiers in Oncology|June 2, 2020
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells <i>in vitro</i>Yuqi Yang, Ning Ji, Qiu-Xu Teng, et al.Journal of Translational Internal Medicine|July 31, 2024
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cellsXing-Duo Dong, Qisi Lu, Yi-Dong Li, et al.International Journal of Molecular Sciences|February 26, 2020
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer CellsJingqiu Wang, Dong-Hua Yang, Yuqi Yang, et al.Biochemical Pharmacology|June 14, 2021
CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)Jing-Quan Wang, Bo Wang, Qiu-Xu Teng, et al.Biochemical Pharmacology|May 13, 2019
Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cellsZhuo-Xun Wu, Qiu-Xu Teng, Chao-Yun Cai, et al.Cancers|January 17, 2020
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug ResistanceZhuo-Xun Wu, Yuqi Yang, Qiu-Xu Teng, et al.Pageof 6